Crossref
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer
Current Breast Cancer Reports · 2009
DOI: 10.1007/s12609-009-0001-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Breast Cancer Reports, 2009. Verfasst von Chau Dang. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dang, C. (2009). Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer. Current Breast Cancer Reports. https://doi.org/10.1007/s12609-009-0001-9
Vancouver
Dang C. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer. Current Breast Cancer Reports. 2009. doi:10.1007/s12609-009-0001-9
BibTeX
@article{Dang2009,
author = {Dang, Chau},
title = {Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer},
journal = {Current Breast Cancer Reports},
year = {2009},
doi = {10.1007/s12609-009-0001-9}
}
EUVIMED